Idogen: Raising capital
Research Note
2020-01-29
04:29
Yesterday, Idogen announced a rights issue of roughly SEK 29 million to finance preparations for an initiation of the first clinical trial in Q1 2021.
LS
Ludvig Svensson
Disclosures and disclaimers